These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1461870)

  • 1. The renal effects of dopamine and dobutamine in stable chronic heart failure.
    Good J; Frost G; Oakley CM; Cleland JG
    Postgrad Med J; 1992; 68 Suppl 2():S7-11. PubMed ID: 1461870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans.
    Olsen NV
    Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine?
    Duke GJ; Briedis JH; Weaver RA
    Crit Care Med; 1994 Dec; 22(12):1919-25. PubMed ID: 7988127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of effects of low-dose dopamine and dobutamine in patients with nonoliguric renal failure].
    Li MQ; Shi ZX; Xu JY; Zhang Z; Lu F; Li L
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Jan; 18(1):51-3. PubMed ID: 16464390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dobutamine on renal sympathetic activity in human heart failure.
    Al-Hesayen A; Parker JD
    J Cardiovasc Pharmacol; 2008 May; 51(5):434-6. PubMed ID: 18398381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
    Kleinschmidt R; Spannbrucker N; Vogel F
    Dtsch Med Wochenschr; 1985 Apr; 110(15):598-603. PubMed ID: 2983969
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohormonal activation, the renal dopaminergic system and sodium handling in patients with severe heart failure under vasodilator therapy.
    Ferreira A; Bettencourt P; Dias P; Pestana M; Serrão P; Soares-da-Silva P; Cerqueira-Gomes M
    Clin Sci (Lond); 2001 May; 100(5):557-66. PubMed ID: 11294697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery.
    Pomer S; Elert O; Sarai K; Satter P
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):77-81. PubMed ID: 3957495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aquaretic effect of lixivaptan, an oral, non-peptide, selective V2 receptor vasopressin antagonist, in New York Heart Association functional class II and III chronic heart failure patients.
    Abraham WT; Shamshirsaz AA; McFann K; Oren RM; Schrier RW
    J Am Coll Cardiol; 2006 Apr; 47(8):1615-21. PubMed ID: 16630999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.
    Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS
    Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of dopamine and dobutamine on renal function and urinary excretion of prostaglandin E2 in elderly postoperative patients].
    Niiya S; Fukusaki M; Nakamura T; Miyoshi H; Ogata K; Miyako M
    Masui; 2001 Feb; 50(2):122-6. PubMed ID: 11244764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of the action of dobutamine in acute cardiac insufficiency].
    Chevalier P; Leylavergne J; Gournay G; Laffay N; Gryman R; Renault C; Guérot C; Valère PE; Tricot R
    Ann Cardiol Angeiol (Paris); 1984; 33(4):227-32. PubMed ID: 6147116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.